Mayo Clinic to Offer Exact Sciences' Non-Invasive Colorectal Cancer Screening Test | GenomeWeb

NEW YORK (GenomeWeb) – Mayo Clinic will be the first health system to offer Exact Sciences' stool DNA-based colorectal cancer screening test, called Cologuard, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.